SALVAGE TREATMENT WITH BENDAMUSTINE, OFATUMUMAB, HIGH-DOSE METHYLPREDNISOLONE (BOMP) IN HIGH-RISK R/R CLL: INTERIM RESULTS OF THE FRENCH CLL INTERGROUP (GCFLLC/MW - GOELAMS) ICLL01 PHASE 2 TRIAL.

Affiliation auteurs!!!! Error affiliation !!!!
TitreSALVAGE TREATMENT WITH BENDAMUSTINE, OFATUMUMAB, HIGH-DOSE METHYLPREDNISOLONE (BOMP) IN HIGH-RISK R/R CLL: INTERIM RESULTS OF THE FRENCH CLL INTERGROUP (GCFLLC/MW - GOELAMS) ICLL01 PHASE 2 TRIAL.
Type de publicationJournal Article
Year of Publication2014
Auteursde Guibert S., Dilhyudy M.S, Ysebaert L., Sanhes L., Choquet S., Aurran-Schleinitz T., Guieze R., Mahe B., Daguindau N., Araujo C., Saad H., Ferrant E., Cazin B., Feugier P., Dreyfus B., Delmer A., Lepretre S., Le Garff-Tavernier M., Veronese L., Nguyen-Khac F., Vilque J.P, Brion A., Dartigeas C., Dupuy J., Tiab M., Foussard C., Delepine R., Leblond V., Tournilhac O.
JournalHAEMATOLOGICA
Volume99
Pagination60–61
Date PublishedJUN 1
Type of ArticleMeeting Abstract
ISSN0390-6078